Hemophilia Gene Therapy: Update
Overview
Authors
Affiliations
Gene transfer is an exciting and potentially important treatment approach for hemophilia A and B. Four phase I clinical trials of the safety of gene transfer in hemophilia A or B have been completed and two more trials are currently underway. The results of these trials indicate that gene transfer in hemophilia with the vectors and doses used is safe and well tolerated. Efforts continue to understand the basic biology and improve the efficiency of gene transfer.
Shi Q, Carman C, Chen Y, Sage P, Xue F, Liang X Blood Adv. 2020; 4(10):2272-2285.
PMID: 32453842 PMC: 7252558. DOI: 10.1182/bloodadvances.2020001468.
An Orthogonal Array Optimization of Lipid-like Nanoparticles for mRNA Delivery in Vivo.
Li B, Luo X, Deng B, Wang J, McComb D, Shi Y Nano Lett. 2015; 15(12):8099-107.
PMID: 26529392 PMC: 4869688. DOI: 10.1021/acs.nanolett.5b03528.
Nichols T, Dillow A, Franck H, Merricks E, Raymer R, Bellinger D ILAR J. 2009; 50(2):144-67.
PMID: 19293459 PMC: 3101868. DOI: 10.1093/ilar.50.2.144.
Isolation and therapeutic potential of human haemopoietic stem cells.
Clark A, Jorgensen H, Mountford J, Holyoake T Cytotechnology. 2008; 41(2-3):111-31.
PMID: 19002948 PMC: 3466700. DOI: 10.1023/A:1024822722285.
Xu L, Nichols T, Sarkar R, McCorquodale S, Bellinger D, Ponder K Proc Natl Acad Sci U S A. 2005; 102(17):6080-5.
PMID: 15837921 PMC: 1087916. DOI: 10.1073/pnas.0409249102.